Aquestive Therapeutics (AQST) Finished Goods (2017 - 2021)

Aquestive Therapeutics' Finished Goods history runs 5 years deep, the most recent figure standing at $1.0 million for Q1 2021.

• In Q1 2021, Finished Goods rose 42.8% year-over-year to $1.0 million; the TTM figure through Mar 2021 stood at $1.0 million (up 42.8% YoY), while the FY2020 annual figure was $544000.0, up 4.82% from the prior year.
• Finished Goods was $1.0 million for Q1 2021 at Aquestive Therapeutics, up from $544000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $1.3 million in Q2 2018 to a low of $519000.0 in Q4 2019.
• Historically, Finished Goods has averaged $958461.5 across 5 years, with a median of $1.0 million in 2019.
• The sharpest annual moves came in 2019 and 2021: Finished Goods slumped 56.13% in 2019, then surged 42.8% in 2021.
• A 5-year view of Finished Goods shows it stood at $1.1 million in 2017, then rose by 11.18% to $1.2 million in 2018, then plunged by 56.13% to $519000.0 in 2019, then increased by 4.82% to $544000.0 in 2020, then surged by 84.01% to $1.0 million in 2021.
• The last three Finished Goods figures came in at $1.0 million (Q1 2021), $544000.0 (Q4 2020), and $858000.0 (Q3 2020), per Business Quant data.